Cellecta Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Cellecta's estimated annual revenue is currently $5.3M per year.(i)
  • Cellecta's estimated revenue per employee is $155,000

Employee Data

  • Cellecta has 34 Employees.(i)
  • Cellecta grew their employee count by 6% last year.

Cellecta's People

NameTitleEmail/Phone
1
Chief Operating Officer, Director Business DevelopmentReveal Email/Phone
2
Director R&DReveal Email/Phone
3
Production ManagerReveal Email/Phone
4
scientistReveal Email/Phone
5
Research ScientistReveal Email/Phone
6
Independent Investigator and ConsultantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Cellecta?

Cellecta provides HT loss-of-function genetic screening services for the discovery and functional characterization of novel therapeutic targets. We offer pooled lentiviral shRNA and CRISPR libraries, pooled library screening and analysis by NGS, targeted RNA-Seq for biomarker discovery, lentiviral reagents, and stable cDNA, shRNA, and CRISPR constructs and isogenic cell lines.

keywords:N/A

N/A

Total Funding

34

Number of Employees

$5.3M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cellecta News

2022-04-20 - Clustered Regularly Interspaced Short Palindromic Repeats ...

... GenScript, Integrated DNA Technologies, Horizon Discovery Group, Agilent Technologies, Cellecta, GeneCopoeia, New England Biolabs, Origene Technologies.

2022-04-20 - CRISPR and Cas Genes Market is Anticipated to Reach US ...

... Inc., Applied StemCell, Inc., Addgene, and Cellecta, Inc. Genome Engineering to Dominate CRISPR and Cas genes market.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.6M34162%$65M
#2
$5.7M34N/AN/A
#3
$1.7M35-3%N/A
#4
$6.9M356%N/A
#5
$3.9M356%$0.15M